MedKoo Cat#: 574782 | Name: (R)-MG132
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

(R)-MG132 is a potent, reversible, and cell permeable proteasome inhibitor. (R)-MG132 is an SRS isomer. MG132 is an SSS isomer.

Chemical Structure

(R)-MG132
(R)-MG132
CAS#1211877-36-9 (SRS-isomer)

Theoretical Analysis

MedKoo Cat#: 574782

Name: (R)-MG132

CAS#: 1211877-36-9 (SRS-isomer)

Chemical Formula: C26H41N3O5

Exact Mass: 475.3046

Molecular Weight: 475.63

Elemental Analysis: C, 65.66; H, 8.69; N, 8.83; O, 16.82

Price and Availability

Size Price Availability Quantity
1mg USD 350.00 2 Weeks
5mg USD 750.00 2 Weeks
10mg USD 1,250.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Synonym
(R)-MG132; (R)-MG-132; (R)-MG 132;
IUPAC/Chemical Name
benzyl ((S)-4-methyl-1-(((R)-4-methyl-1-(((S)-4-methyl-1-oxopentan-2-yl)amino)-1-oxopentan-2-yl)amino)-1-oxopentan-2-yl)carbamate
InChi Key
TZYWCYJVHRLUCT-ZRBLBEILSA-N
InChi Code
InChI=1S/C26H41N3O5/c1-17(2)12-21(15-30)27-24(31)22(13-18(3)4)28-25(32)23(14-19(5)6)29-26(33)34-16-20-10-8-7-9-11-20/h7-11,15,17-19,21-23H,12-14,16H2,1-6H3,(H,27,31)(H,28,32)(H,29,33)/t21-,22+,23-/m0/s1
SMILES Code
[C@H](NC([C@@H](NC(OCC1=CC=CC=C1)=O)CC(C)C)=O)(C(N[C@@H](CC(C)C)C=O)=O)CC(C)C
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 475.63 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1. Lee, D.H., and Goldberg, A.L. Proteasome inhibitors: Valuable new tools for cell biologists. Trends in Cell Biology 8, 397-403 (1998). 2. Elliott, P.J., Zollner, T.M., and Boehncke, W.H. Proteasome inhibition: A new anti-inflammatory strategy. Journal of Molecular Medicine 81, 235-245 (2003). 3. Mroczkiewicz, M., Winkler, K., Nowis, D., et al. Studies of the synthesis of all stereoisomers of MG-132 proteasome inhibitors in the tumor targeting approach. Journal of Medicinal Chemistry 53, 1509-1518 (2010). Product Citations Change, Y.-C., Chen, Y.-J., Huang, C.-W., et al. Cyclic stretch facilitates myogenesis in C2C12 myoblasts and rescues thiazolidinedione-inhibited myotube formation. Front. Bioeng. Biotechnol. 4(27), (2016). 5: Jing, H., Shen, G., Wang, G., Zhang, F., Li, Y., Luo, F., ... & Tian, X. F. (2012). MG132 alleviates liver injury induced by intestinal ischemia/reperfusion in rats: involvement of the AhR and NFκB pathways. Journal of Surgical Research, 176(1), 63-73. 6: Yin, H., Jiang, Y., Li, H., Li, J., Gui, Y., & Zheng, X. L. (2011). Proteasomal degradation of myocardin is required for its transcriptional activity in vascular smooth muscle cells. Journal of cellular physiology, 226(7), 1897-1906.